98 related articles for article (PubMed ID: 11993444)
1. Getting an extension.
Diabetes Obes Metab; 2002 Mar; 4(2):139-40. PubMed ID: 11993444
[No Abstract] [Full Text] [Related]
2. New treatments for diabetes.
Raz I; Eldor R
N Engl J Med; 2007 May; 356(21):2222; author reply 2222-3. PubMed ID: 17526096
[No Abstract] [Full Text] [Related]
3. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
[No Abstract] [Full Text] [Related]
4. Treatment of type 2 diabetes mellitus and the incretin system.
Whitehill D
S D Med; 2007 May; 60(5):197, 199. PubMed ID: 17694940
[No Abstract] [Full Text] [Related]
5. Metaglip and Avandamet for type 2 diabetes.
Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
[No Abstract] [Full Text] [Related]
6. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
7. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
8. Do we need new drugs for the treatment of type 2 diabetes mellitus?
Vervoort G; Tack CJ
Neth J Med; 2007 May; 65(5):157-9. PubMed ID: 17519510
[No Abstract] [Full Text] [Related]
9. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
Halimi S
Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
[No Abstract] [Full Text] [Related]
10. Insulin monotherapy vs. combination therapy.
Ebell MH
Am Fam Physician; 2005 Mar; 71(5):899. PubMed ID: 15768618
[No Abstract] [Full Text] [Related]
11. Combination of drugs in the management of diabetes mellitus.
Das S
J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
[TBL] [Abstract][Full Text] [Related]
12. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
13. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
Mansour AA; Habib OS
Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
[No Abstract] [Full Text] [Related]
14. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
15. [Metformin role in the treatment of type 2 diabetes in 2008].
Spada A; Philippe J
Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
[TBL] [Abstract][Full Text] [Related]
16. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye H
Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
[No Abstract] [Full Text] [Related]
18. Follow-up of intensive glucose control in type 2 diabetes.
Mühlhauser I
N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
[No Abstract] [Full Text] [Related]
19. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
Viswanathan V; Chacko PT; Lavanya M; Tilak P
J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
[No Abstract] [Full Text] [Related]
20. Metformin in heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Diabetes Care; 2007 Dec; 30(12):e129. PubMed ID: 18042738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
